BY4 (Primaquine phosphate 15mg (base))

Pill imprint BY4 has been identified as Primaquine phosphate 15mg (base).

Primaquine is used in the treatment of malaria prevention; malaria; pneumocystis pneumonia and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 15mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Primaquine phosphate

Imprint:

BY4

Strength:

15mg (base)

Color:

Purple

Shape:

Round

Availability:

Prescription only

Drug Class:

Antimalarial quinolines

Pregnancy Category:

N - Not classified

CSA Schedule:

Not a controlled drug

Manufacturer:

Bayshore Pharmaceuticals, LLC

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.